TY - JOUR
T1 - Preoperative angiographic considerations and neurological outcome after surgical treatment of intradural spinal hemangioblastoma
T2 - a multicenter retrospective case series
AU - Butenschoen, Vicki M.
AU - Schwendner, Maximilian
AU - Hubertus, Vanessa
AU - Onken, Julia
AU - Koegl, Nikolaus
AU - Mohme, Theresa
AU - Maurer, Stefanie
AU - Boeckh-Behrens, Tobias
AU - Eicker, Sven O.
AU - Thomé, Claudius
AU - Vajkoczy, Peter
AU - Czabanka, Marcus
AU - Meyer, Bernhard
AU - Wostrack, Maria
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2023/1
Y1 - 2023/1
N2 - Purpose: Intradural spinal hemangioblastomas are rare highly hypervascularized benign neoplasms. Surgical resection remains the treatment of choice, with a significant risk of postoperative neurological deterioration. Due to the tumor infrequency, scientific evidence is scarce and limited to case reports and small case series. Methods: We performed a retrospective multicenter study including five high-volume neurosurgical centers analyzing patients surgically treated for spinal hemangioblastomas between 2006 and 2021. We assessed clinical status, surgical data, preoperative angiograms, and embolization when available. Follow-up records were analyzed, and logistic regression performed to assess possible risk factors for neurological deterioration. Results: We included 60 patients in Germany and Austria. Preoperative angiography was performed in 30% of the cases; 10% of the patients underwent preoperative embolization. Posterior tumor location and presence of a syrinx favored gross total tumor resection (93.8% vs. 83.3% and 97.1% vs. 84%). Preoperative embolization was not associated with postoperative worsening. The clinical outcome revealed a transient postoperative neurological deterioration in 38.3%, depending on symptom duration and preoperative modified McCormick grading, but patients recovered in most cases until follow-up. Conclusion: Spinal hemangioblastoma patients significantly benefit from early surgical treatment with only transient postoperative deterioration and complete recovery until follow-up. The performance of preoperative angiograms remains subject to center disparities.
AB - Purpose: Intradural spinal hemangioblastomas are rare highly hypervascularized benign neoplasms. Surgical resection remains the treatment of choice, with a significant risk of postoperative neurological deterioration. Due to the tumor infrequency, scientific evidence is scarce and limited to case reports and small case series. Methods: We performed a retrospective multicenter study including five high-volume neurosurgical centers analyzing patients surgically treated for spinal hemangioblastomas between 2006 and 2021. We assessed clinical status, surgical data, preoperative angiograms, and embolization when available. Follow-up records were analyzed, and logistic regression performed to assess possible risk factors for neurological deterioration. Results: We included 60 patients in Germany and Austria. Preoperative angiography was performed in 30% of the cases; 10% of the patients underwent preoperative embolization. Posterior tumor location and presence of a syrinx favored gross total tumor resection (93.8% vs. 83.3% and 97.1% vs. 84%). Preoperative embolization was not associated with postoperative worsening. The clinical outcome revealed a transient postoperative neurological deterioration in 38.3%, depending on symptom duration and preoperative modified McCormick grading, but patients recovered in most cases until follow-up. Conclusion: Spinal hemangioblastoma patients significantly benefit from early surgical treatment with only transient postoperative deterioration and complete recovery until follow-up. The performance of preoperative angiograms remains subject to center disparities.
KW - Embolization
KW - Neurological outcome
KW - Spinal hemangioblastoma
KW - Vascularization
UR - http://www.scopus.com/inward/record.url?scp=85144834034&partnerID=8YFLogxK
U2 - 10.1007/s11060-022-04213-2
DO - 10.1007/s11060-022-04213-2
M3 - Article
C2 - 36566460
AN - SCOPUS:85144834034
SN - 0167-594X
VL - 161
SP - 107
EP - 115
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 1
ER -